Modern Synthesis

London, United Kingdom Founded: 2019 • Age: 7 yrs
Biomaterials are developed via microbial fermentation for diverse applications.

About Modern Synthesis

Modern Synthesis is a Retail company based in London (United Kingdom) founded in 2019 by Ben Reeve and Jen Keane. Biomaterials are developed via microbial fermentation for diverse applications. It operates in the Retail and Chemicals & Materials sectors. Modern Synthesis has raised $9.6 million across 2 funding rounds from investors including ARTESIAN PARTNERS, Petri Bio and Parley for the Oceans. Its chief executive, as recorded, is Jen Keane. Its Indian entity Ironsource India Private Limited reported revenue of β‚Ή21.75 Cr. Modern Synthesis offers products and services including Nanocellulose and Microcraft. Its focus areas include Consumer, Fashion Tech, Innovative Materials and Sustainable Fabrics. Its competitors include Heartbeat, WIDDOP and First Editions.

Company details

Modern Synthesis was founded in 2019 in London, United Kingdom, within the biotechnology sector. Microbes are engineered to convert agricultural sugars into nanocellulose, producing customizable materials that replace animal- and fossil-fuel-derived options. Biology, material science, engineering, and design are integrated in the process to create circular solutions. Collaborations with companies are pursued to tackle issues such as greenhouse gas emissions, waste, land use, plastic pollution, and animal welfare.

  • Headquarters London, United Kingdom
  • Founders Ben Reeve, Jen Keane
  • Sectors
    Retail
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website modernsynthesis.com
  • Social LinkedIn Instagram
  • Legal Name Modern Synthesis Limited
  • Date of Incorporation 04 Jul, 2019
  • Jurisdiction LONDON, ENGLAND
Key Metrics
  • Indian entity revenue
    ₹21.75 Cr

    FY 2025 · +206% YoY

  • Indian entity net profit
    ₹3.79 Cr

    FY 2025 · 17% margin

  • Indian entity EBITDA
    ₹5.88 Cr

    FY 2025 · 27% margin

  • Total Equity Funding
    $9.6M (USD)

    in 2 rounds

  • Latest Funding Round
    $5.5M (USD), Seed

    Feb 2025

  • Investors

Products & Services of Modern Synthesis

Modern Synthesis offers a comprehensive portfolio of products and services, including Nanocellulose and Microcraft.

Nanocellulose
Biomaterial

Sustainable fiber from microbes replacing plastics in textiles

Microcraft
Textile Innovation

Redefines craft using nanomaterials for eco-friendly applications

Funding Insights of Modern Synthesis

Modern Synthesis has successfully raised a total of $9.6M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $5.5 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $9.6M
  • Total Rounds 2
  • Last Round Seed β€” $5.5M
  • First Round $4.1M

    (Jun 2022)

  • Investors Count 13

All 2 funding rounds of Modern Synthesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2025$5.5MSeed–Extantia
Jun 2022$4.1MSeed––
Valuation history

13 investors in total: 12 institutional and 1 angel.

Investors in Modern Synthesis

Modern Synthesis has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include ARTESIAN PARTNERS, Petri Bio and Parley for the Oceans.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Extantia is focused on investing in climate technology pioneers.
extantia.com
Private equity firm investing in multiple sectors
collabfund.comNew York, United States
Single family office focused on multiple sectors
2021artesian.comDenver, United States
Venture capital fund focused on ag-tech and food-tech sectors
agfunder.comSan Francisco, United States
Investments are made in early-stage tech companies by Acequia Capital.
acecap.comSeattle, United States
Early-stage investments across multiple sectors are conducted by this firm.
possible.venturesMunich, Germany
VC firm investing in tech startups across US and China
imo.vcSan Mateo, United States
Investments in tech startups are made by Taihill Venture.
taihill.vcCambridge, United States
Venture capital is invested in climate tech startups and entrepreneurs.
climatecapital.coSan Francisco, United States
Microbe-based drugs are manufactured by Petri Bio in biotechnology.
2019petribio.comLos Angeles, United States
Premium access

Investor details for Modern Synthesis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Ironsource India Private Limited (Modern Synthesis)

Ironsource India Private Limited is the primary company behind Modern Synthesis. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Nora Sen Go
DIN 10531941
Director04 Mar 20242 yrs 8 moIronsource India Private Limited
Bhagavant Bedi
DIN 08005696
Director21 Nov 20241 yr 11 moIronsource India Private Limited
Jasmine De Layton
DIN 10792925
Director08 Jul 20251 yr 4 moIronsource India Private Limited
Shridhar Subbaraman Iyer
DIN 07151577
Director30 Oct 20251 yrIronsource India Private Limited

People of Modern Synthesis

10 people are tracked at Modern Synthesis (4 in leadership, 6 in team).

NameRoleGroup
Ben Reeve
Co-FounderLeadership
Jen Keane
Co-Founder & CEOLeadership
Neil Buckney
Head of EngineeringLeadership
Sarah West Young
Head of GrowthLeadership
Isaac Hiorns
Senior Materials And Manufacturing EngineerTeam
Ioannis Zampetakis
Senior Scientist Group LeadTeam
Louis Graham
People And Culture ManagerTeam
Christopher Chew
PortfolioTeam
Alice Potts
Senior Innovation Concept DesignerTeam
Teodóra Gál
Biomaterials Chemist Project LeadTeam
Premium access

Complete people profiles for Modern Synthesis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Modern Synthesis

Figures of Ironsource India Private Limited, the primary company behind Modern Synthesis, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.

  • ₹21.75 CrRevenue · FY 2025 · +206% YoY
  • ₹3.79 CrNet profit · 17% margin
  • ₹5.88 CrEBITDA · 27% margin
  • ₹1 LakhPaid-up capital
  • 21Employees (provident fund records)
  • +87%Revenue CAGR, 3 years
  • +59%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.

Premium access

Detailed financial statements for Modern Synthesis

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Modern Synthesis

3 dated milestones of Modern Synthesis across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Modern Synthesis is founded.
  2. Funding First funding round of $4.1M.
  3. Funding Latest funding round, Seed, of $5.5M.

Competitors of Modern Synthesis

Modern Synthesis has 3 listed competitors in our database. They include Heartbeat, WIDDOP and First Editions.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
heartbeatuk.com1946Redditch, United Kingdom98
Contract manufacturing of furniture and shop design products is provided.
widdop.co.uk1883Oldham, United Kingdom
Home decor products are manufactured on contract by Widdop.
firsteditionsltd.com1994Birmingham, United Kingdom11
Bottles are manufactured on a contract basis for various clients.
Premium access

Detailed competitors of Modern Synthesis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Modern Synthesis

Premium access

Complete news archive for Modern Synthesis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Modern Synthesis

Modern Synthesis was founded in 2019 and raised its 1st funding round 3 years after it was founded.

Modern Synthesis is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Jen Keane is the CEO of Modern Synthesis, as recorded in our data. They have also founded this company.

Modern Synthesis is a funded company, having raised a total of $9.6M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4.1M, raised on Jun 2022.

The primary company behind Modern Synthesis, Ironsource India Private Limited, reported revenue of β‚Ή21.75 Cr for FY 2025, up 206% year on year.

Modern Synthesis was founded in 2019 in London, United Kingdom, within the biotechnology sector. Microbes are engineered to convert agricultural sugars into nanocellulose, producing customizable materials that replace animal- and fossil-fuel-derived options. Biology, material science, engineering, and design are integrated in the process to create circular solutions. Collaborations with companies are pursued to tackle issues such as greenhouse gas emissions, waste, land use, plastic pollution, and animal welfare.

Modern Synthesis's top competitors include Heartbeat, WIDDOP and First Editions.

Modern Synthesis offers Nanocellulose and Microcraft.

Modern Synthesis has 13 investors. Key investors include ARTESIAN PARTNERS, Petri Bio, Parley for the Oceans, Extantia, and Collab Fund.

Modern Synthesis operates through Ironsource India Private Limited.

The legal entities of Modern Synthesis currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available